FdaApplication
ANDA 212552
Identifiers
- fda_app_no: ANDA212552
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2026-03-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIRAGLUTIDE | LIRAGLUTIDE | 18MG/3ML (6MG/ML) | SOLUTION;SUBCUTANEOUS |
1 product